Inter Pharma PCL (BKK: IP)
Thailand
· Delayed Price · Currency is THB 3.580
+0.080 (2.29%)
Nov 20, 2024, 4:37 PM ICT
Inter Pharma PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Operating Revenue | 1,793 | 1,781 | 1,523 | 908.63 | 442.1 | 371.33 | Upgrade
|
| Other Revenue | 15.97 | 17.54 | 11.12 | 12.35 | 4.84 | 4.56 | Upgrade
|
| Revenue | 1,809 | 1,799 | 1,534 | 920.98 | 446.94 | 375.88 | Upgrade
|
| Revenue Growth (YoY) | 1.92% | 17.23% | 66.61% | 106.07% | 18.90% | 18.36% | Upgrade
|
| Cost of Revenue | 1,144 | 1,122 | 905.42 | 507.85 | 182.77 | 157.39 | Upgrade
|
| Gross Profit | 665.39 | 676.98 | 629.03 | 413.14 | 264.17 | 218.5 | Upgrade
|
| Selling, General & Admin | 607.42 | 567.58 | 458.23 | 267.36 | 187.22 | 156.73 | Upgrade
|
| Operating Expenses | 607.42 | 567.58 | 458.23 | 267.36 | 187.22 | 156.73 | Upgrade
|
| Operating Income | 57.98 | 109.4 | 170.8 | 145.77 | 76.95 | 61.77 | Upgrade
|
| Interest Expense | -22.51 | -25.76 | -23.34 | -8.01 | -1.14 | -0.59 | Upgrade
|
| Earnings From Equity Investments | -2.3 | -2.27 | -0.77 | -0.08 | -0.16 | -0.22 | Upgrade
|
| EBT Excluding Unusual Items | 33.16 | 81.37 | 146.69 | 137.68 | 75.65 | 60.95 | Upgrade
|
| Pretax Income | 33.16 | 81.37 | 146.69 | 137.68 | 75.65 | 60.95 | Upgrade
|
| Income Tax Expense | 11.72 | 22.47 | 19.41 | 27.2 | 16.39 | 13.82 | Upgrade
|
| Earnings From Continuing Operations | 21.44 | 58.9 | 127.29 | 110.48 | 59.26 | 47.13 | Upgrade
|
| Minority Interest in Earnings | -1.05 | -8.11 | -8.4 | -5.27 | -6.72 | -3.66 | Upgrade
|
| Net Income | 20.39 | 50.79 | 118.88 | 105.22 | 52.54 | 43.47 | Upgrade
|
| Net Income to Common | 20.39 | 50.79 | 118.88 | 105.22 | 52.54 | 43.47 | Upgrade
|
| Net Income Growth | -81.16% | -57.28% | 12.99% | 100.27% | 20.85% | 46.47% | Upgrade
|
| Shares Outstanding (Basic) | 605 | 605 | 532 | 475 | 470 | 356 | Upgrade
|
| Shares Outstanding (Diluted) | 605 | 605 | 532 | 475 | 470 | 356 | Upgrade
|
| Shares Change (YoY) | 2.16% | 13.78% | 11.97% | 1.05% | 31.92% | 40.33% | Upgrade
|
| EPS (Basic) | 0.03 | 0.08 | 0.22 | 0.22 | 0.11 | 0.12 | Upgrade
|
| EPS (Diluted) | 0.03 | 0.08 | 0.22 | 0.22 | 0.11 | 0.12 | Upgrade
|
| EPS Growth | -81.56% | -62.45% | 0.91% | 98.19% | -8.39% | 4.37% | Upgrade
|
| Free Cash Flow | 20.6 | 14.96 | 115.72 | -265.73 | -21.27 | 4.41 | Upgrade
|
| Free Cash Flow Per Share | 0.03 | 0.02 | 0.22 | -0.56 | -0.05 | 0.01 | Upgrade
|
| Dividend Per Share | 0.021 | 0.021 | 0.111 | - | 0.010 | 0.081 | Upgrade
|
| Dividend Growth | -80.69% | -80.69% | - | - | -87.33% | 107.93% | Upgrade
|
| Gross Margin | 36.78% | 37.64% | 40.99% | 44.86% | 59.11% | 58.13% | Upgrade
|
| Operating Margin | 3.20% | 6.08% | 11.13% | 15.83% | 17.22% | 16.43% | Upgrade
|
| Profit Margin | 1.13% | 2.82% | 7.75% | 11.42% | 11.75% | 11.57% | Upgrade
|
| Free Cash Flow Margin | 1.14% | 0.83% | 7.54% | -28.85% | -4.76% | 1.17% | Upgrade
|
| EBITDA | 95.94 | 167.66 | 208.7 | 170.85 | 82.14 | 63.62 | Upgrade
|
| EBITDA Margin | 5.30% | 9.32% | 13.60% | 18.55% | 18.38% | 16.93% | Upgrade
|
| D&A For EBITDA | 37.96 | 58.25 | 37.9 | 25.08 | 5.19 | 1.85 | Upgrade
|
| EBIT | 57.98 | 109.4 | 170.8 | 145.77 | 76.95 | 61.77 | Upgrade
|
| EBIT Margin | 3.20% | 6.08% | 11.13% | 15.83% | 17.22% | 16.43% | Upgrade
|
| Effective Tax Rate | 35.34% | 27.61% | 13.23% | 19.75% | 21.67% | 22.68% | Upgrade
|
| Revenue as Reported | 1,809 | 1,799 | 1,534 | 920.98 | 446.94 | 375.88 | Upgrade
|
| Advertising Expenses | - | 70.61 | 31.91 | 41.13 | 36.63 | 19.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.